DFTX Stock-Based Compensation

Definium Therapeutics Inc · Stock-Based Compensation

DFTX logo

DFTX Stock-Based Compensation

Latest reported$34.00M
DFTX TTM Stock-Based Comp ($0.00 → $34.00M)
High-resolution chart · PNG

DFTX stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Definium Therapeutics Inc Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
34,004,000
29,618,000
25,912,000
17,940,000
15,894,000
16,071,000
16,334,000
16,565,000
17,021,000
15,433,000
15,494,000
13,194,000
13,254,000
13,665,000
13,707,000
23,370,000
23,190,000
51,925,000
49,412,000
43,487,032
43,402,032
8,270,032
6,991,032
1,877,000
-2,144,000
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.